Tandem Diabetes Care (TNDM) news
Recent news
Tandem Diabetes Care, Inc.: Citigroup cuts target price to $20 from $24
Tandem Diabetes Care, Inc. (NASDAQ: TNDM) recently saw its price target cut by Citigroup, which lowered its forecast to $20 , according to a recent report. This adjustment comes amid a broader range of analyst activity, with several firms maintaining a "Hold" rating and a median price target of…
AInvest Wire · Sep 30, 2026Tandem Diabetes Care gets upside 90-day catalyst watch at Cit
Tandem Diabetes Care, Inc. (NASDAQ: TNDM) has been placed on a 90-day upside catalyst watch by Citigroup, reflecting ongoing investor interest in the diabetes technology company amid recent market developments. Shares of Tandem have experienced notable volatility in recent months, with a 2.5%…
AInvest Wire · Sep 30, 2026Tandem Diabetes Care Q2 EPS USD -0.31
AInvest Wire · Aug 6, 2026Tandem Diabetes shares slump 17% after posting 2Q results
AInvest Wire · Aug 6, 2026Tandem Diabetes Care Inc: UBS cuts target price to $18 from $22
Tandem Diabetes Care Inc. (TNDM) has seen a recent adjustment in analyst sentiment, with UBS lowering its price target for the stock to $18 from $22, reflecting a 18.46% downside from the current price level. This move aligns with a broader range of analyst actions over the past several months,…
AInvest Wire · Jul 28, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.